Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression.

Developmental biology | 2011

Nkx2.2 and Arx are essential pancreatic transcription factors. Nkx2.2 is necessary for the appropriate specification of the islet alpha, beta, PP and epsilon cell lineages, whereas Arx is required to form the correct ratio of alpha, beta, delta and PP cells. To begin to understand the cooperative functions of Nkx2.2 and Arx in the development of endocrine cell lineages, we generated progenitor cell-specific deletions of Arx on the Nkx2.2 null background. The analysis of these mutants demonstrates that expansion of the ghrelin cell population in the Nkx2.2 null pancreas is not dependent on Arx; however, Arx is necessary for the upregulation of ghrelin mRNA levels in Nkx2.2 mutant epsilon cells. Alternatively, in the absence of Arx, delta cell numbers are increased and Nkx2.2 becomes essential for the repression of somatostatin gene expression. Interestingly, the dysregulation of ghrelin and somatostatin expression in the Nkx2.2/Arx compound mutant (Nkx2.2(null);Arx(Δpanc)) results in the appearance of ghrelin+/somatostatin+ co-expressing cells. These compound mutants also revealed a genetic interaction between Nkx2.2 and Arx in the regulation of the PP cell lineage; the PP cell population is reduced when Nkx2.2 is deleted but is restored back to wildtype numbers in the Nkx2.2(null);Arx(Δpanc) mutant. Moreover, conditional deletion of Arx in specific pancreatic cell populations established that the functions of Arx are necessary in the Neurog3+ endocrine progenitors. Together, these experiments identify novel genetic interactions between Nkx2.2 and Arx within the endocrine progenitor cells that ensure the correct specification and regulation of endocrine hormone-producing cells.

Pubmed ID: 21856296 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: P30-HD26979
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072504-03
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK082590-04
  • Agency: NICHD NIH HHS, United States
    Id: P30 HD026979
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK089523
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072504-04
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072504
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK082590-03
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072504-05
  • Agency: NIDDK NIH HHS, United States
    Id: P30-DK63608
  • Agency: NIDDK NIH HHS, United States
    Id: P30-DK19525
  • Agency: NIDDK NIH HHS, United States
    Id: U01-DK072504
  • Agency: NINDS NIH HHS, United States
    Id: R01-NS46616
  • Agency: NIDDK NIH HHS, United States
    Id: R01-DK082590
  • Agency: NIDDK NIH HHS, United States
    Id: R56 DK078606
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072504-01
  • Agency: NIDDK NIH HHS, United States
    Id: U01-DK089523
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS046616
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072504-02
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK082590
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK082590-02
  • Agency: NIDDK NIH HHS, United States
    Id: DK078606
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK078606
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063608
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK019525

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phoenix Pharmaceuticals (tool)

RRID:SCR_001141

Commercial antibody supplier that specializes in peptide-related products for research in obesity, cardiovascular disease, and diabetes.

View all literature mentions